---
schema_version: "secwatch.filing_event.v1"
accession: "0001725160-26-000049"
form_type: "8-K"
ticker: "ZNTL"
cik: "0001725160"
company_name: "Zentalis Pharmaceuticals, Inc."
filed_at: "2026-05-27T20:07:11+00:00"
generated_at: "2026-05-27T20:11:26.806584+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Zentalis appoints Shannon Campbell as Class I director, expanding board to 7 members

## Summary
- Board increased from 6 to 7 directors; Campbell appointed as Class I director effective May 22, 2026.
- Annual retainer of $45,000 for board service plus $7,500 for Compensation Committee membership.
- Granted RSUs covering 114,200 shares on May 26, 2026, vesting one-third annually over three years.
- After 6 months, eligible for annual equity grant of RSUs covering 0.08% of outstanding shares.

## SEC filing metadata
- accession: 0001725160-26-000049
- form_type: 8-K
- ticker: ZNTL
- cik: 0001725160
- company_name: Zentalis Pharmaceuticals, Inc.
- filed_at: 2026-05-27T20:07:11+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725160/000172516026000049/0001725160-26-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725160/000172516026000049/zntl-20260522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001725160-26-000049
- JSON: https://secwatch.observer/filing/0001725160-26-000049.json
- Plain text: https://secwatch.observer/filing/0001725160-26-000049.txt

## Source-grounded claims
- claim_id: 9642ea7149
  claim: Shannon Campbell was appointed as Director at Zentalis Pharmaceuticals, Inc..
  evidence_excerpt: Effective May 22, 2026, the Board of Directors (the “Board”) of Zentalis Pharmaceuticals, Inc. (the “Company”) increased its size from six to seven directors and appointed Shannon Campbell, as a Class I director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725160/000172516026000049/0001725160-26-000049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.